Rethinking drug design in the artificial intelligence era
Petra Schneider(ETH Zurich), W. Patrick Walters(Relay Therapeutics (United States)), Alleyn T. Plowright(Sanofi (Germany)), Norman Sieroka(University of Bremen), Jennifer Listgarten(University of California, Berkeley), Robert A. Goodnow, Jasmin Fisher(University of Cambridge), Johanna M. Jansen(Novartis (United States)), José S. Duca(Novartis (United States)), Thomas S. Rush, Matthias Zentgraf(Boehringer Ingelheim (Germany)), John E. Hill, Elizabeth Krutoholow, Matthias Köhler(ETH Zurich), Jeff Blaney, Kimito Funatsu(The University of Tokyo), Chris Luebkemann(ETH Zurich), Gisbert Schneider(ETH Zurich)
Cited by 845
Abstract
Related Papers
No related papers found
Powered by citation graph analysis